# Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants

> **NCT00744419** · PHASE1 · COMPLETED · sponsor: **University of Louisville** · enrollment: 24 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** pantoprazole

## Key facts

- **NCT ID:** NCT00744419
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00744419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00744419, "Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00744419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*